Conway Capital Management, Inc. Citius Pharmaceuticals, Inc. Transaction History

Conway Capital Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Dec 02, 2024	SELL	$1.38 - $1.89 $27,599 - $37,800	-20,000 Closed	0 $0
Q2 2021 Dec 02, 2024	SELL	$1.51 - $4.23 $15,100 - $42,300	-10,000 Reduced 33.33%	20,000 $69.6 Million
Q1 2021 Dec 02, 2024	BUY	$1.04 - $2.34 $31,200 - $70,200	30,000 New	30,000 $53.4 Million

23.7M

83.1K

32.1K

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $399M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Conway Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Conway Capital Management, Inc. with notifications on news.